Bell-Kenz files cyber libel raps vs Leachon
MANILA, Philippines — Health reform advocate Tony Leachon is facing cyber libel charges filed yesterday by Bell-Kenz Pharma Inc.
Balita.org: Your Premier Source for Comprehensive Philippines News and Insights! We bring you the latest news, stories, and updates on a wide range of topics, including politics, culture, economy, and more. Stay tuned to know everything you wish about your favorite stars 24/7.
MANILA, Philippines — Health reform advocate Tony Leachon is facing cyber libel charges filed yesterday by Bell-Kenz Pharma Inc.
TOKYO, Japan — Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, or "beni koji", meant to lower cholesterol.
MANILA, Philippines — Former senator Richard Gordon calls the Pharmally Pharmaceutical Corp. scandal the “biggest scam.”
MANILA, Philippines — A pharmaceutical company has filed cyber libel charges against Anthony Leachon, a health reform advocate and former special adviser for non-communicable diseases at the Department of Health, following his statements alleging a scheme between doctors and the company.
MANILA, Philippines — Pharmaceutical firm Bell-Kenz Pharma Inc. is turning the tables on those who accused the company of engaging in a “prescription for sale” scheme.
MANILA, Philippines — The Department of Health (DOH), the Food and Drug Administration (FDA) and the Professional Regulation Commission (PRC) are set to conduct an investigation on the alleged unethical practices of a local pharmaceutical company owned by physicians.
To safeguard the integrity of the medical profession in the country, Senator Christopher "Bong" Go has proposed implementing a Philippine version of the U.S. Stark Law, or the physicians' self-referral law, aiming to prohibit physicians from financially benefiting from patient referrals to specific healthcare services.
MANILA, Philippines — Amid the “prescription for sale” controversy, all pharmaceutical and other medical supply companies are reminded to submit reports on financial relationships with health care providers to the Food and Drug Administration.